Company Opyl Limited Australian S.E.
Equities
OPL
AU0000062838
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
06/06 | Opyl Secures First TrialGen Contract with Brain Vector | MT |
29/04 | Opyl Expands TrialKey Coverage; Shares Up 38% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Project
57.3
%
| 1 | 69.5 % | 0 | 57.3 % | -43.56% |
Retainer
42.0
%
| 0 | 28.1 % | 0 | 42.0 % | +2.42% |
Other
0.7
%
| 0 | 2.4 % | 0 | 0.7 % | -80.14% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -31.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Jain
CEO | Chief Executive Officer | - | 24/11 |
Marc Angelone
FOU | Founder | - | 17/94/17 |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | 30/19/30 |
Shane Lewis
SAM | Sales & Marketing | - | - |
David Lilja
SEC | Corporate Secretary | - | 10/19/10 |
Jason D. Weaver
PRN | Corporate Officer/Principal | - | 17/17/17 |
Scott Sorochak
PRN | Corporate Officer/Principal | - | 30/17/30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
BRD | Director/Board Member | 54 | 04/23/04 |
Antanas Guoga
BRD | Director/Board Member | 50 | 04/23/04 |
Marc Angelone
FOU | Founder | - | 17/94/17 |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | 30/19/30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 124,527,257 | 80,660,363 ( 64.77 %) | 0 | 64.77 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-4.94% | 29.58B | |
+49.49% | 9.98B | |
+34.36% | 4.4B | |
-42.11% | 2.19B | |
-9.44% | 1.6B | |
-28.06% | 1.24B | |
-42.92% | 978M | |
+8.65% | 972M | |
-47.18% | 735M |
- Stock Market
- Equities
- OPL Stock
- OPL Stock
- Company Opyl Limited